Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
XiaoXiao Jia, Ming Shi, Qifei Wang, Jessica Hui, Joshua Hui Shofaro, Ryenchindorj Erkhembayar, Mizhou Hui, Chenzhe Gao & Munkh-Amgalan Gantumur. (2023) Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35). Journal of Inflammation Research 16, pages 209-224.
Read now
Read now
Indrajit Ghosh, Hiten Gutka, Mary E. Krause, Ryan Clemens & Ramesh S. Kashi. (2023) A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations. mAbs 15:1.
Read now
Read now
Kyle P. Martin, Christine Grimaldi, Rolf Grempler, Steven Hansel & Sandeep Kumar. (2023) Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics. mAbs 15:1.
Read now
Read now
Robert J. Connor, Renee Clift & David W. Kang. (2023) Identifying a predictive relationship between maximal flow rate and viscosity for subcutaneous administration of macromolecules with recombinant human hyaluronidase PH20 in a miniature pig model. Drug Delivery 30:1.
Read now
Read now
B. Rama & A. J. Ribeiro. (2023) Role of nanotechnology in the prolonged release of drugs by the subcutaneous route. Expert Opinion on Drug Delivery 20:5, pages 559-577.
Read now
Read now
Yufang Wang, Chunrong Chen, Yanfang Lin, Meihua Chen, Jinxiang Cai, Xiujuan Chen, Saizhen Chen, Xiaomei Huang & Yanjuan Lin. (2022) Polyurethane foam dressings ameliorating local adverse effects of azacitidine: a randomized controlled trial. Leukemia & Lymphoma 63:3, pages 703-709.
Read now
Read now
Advait V Badkar, Rajesh B Gandhi, Shawn P Davis & Michael J LaBarre. (2021) Subcutaneous Delivery of High-Dose/Volume Biologics: Current Status and Prospect for Future Advancements. Drug Design, Development and Therapy 15, pages 159-170.
Read now
Read now
Stephen P. Knowles, Marie A. Printz, David W. Kang, Michael J. LaBarre & Renee P. Tannenbaum. (2021) Safety of recombinant human hyaluronidase PH20 for subcutaneous drug delivery. Expert Opinion on Drug Delivery 18:11, pages 1673-1685.
Read now
Read now
Barry Paul, Issam Hamadeh, Shebli Atrash, Manisha Bhutani, Peter Voorhees & Saad Z. Usmani. (2020) Daratumumab subcutaneous formulation for the treatment of multiple myeloma. Expert Opinion on Biological Therapy 20:11, pages 1253-1259.
Read now
Read now
Barry Paul, Shebli Atrash, Manisha Bhutani, Peter Voorhees, Issam Hamadeh & Saad Z. Usmani. (2020) An evaluation of subcutaneous daratumumab for the treatment of multiple myeloma. Expert Review of Hematology 13:8, pages 795-802.
Read now
Read now
Cholpon Tilegenova, Saeed Izadi, Jianping Yin, Christine S. Huang, Jiansheng Wu, Diego Ellerman, Sarah G. Hymowitz, Benjamin Walters, Cleo Salisbury & Paul J. Carter. (2020) Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies. mAbs 12:1.
Read now
Read now
Articles from other publishers (66)
P. A. Zeynalova, O. L. Timofeeva, Yu. E. Ryabukhina, F. M. Abbasbeyli, N. A. Kupryshina, A. G. Zhukov & T. T. Valiev. (2023) Use of daratumumab drug formulation for subcutaneous administration in multiple myeloma therapy: Literature review and clinical observation. MD-Onco 3:4, pages 16-27.
Crossref
Crossref
Naoual Dahmana, Pierre-Louis Destruel, Samantha Facchetti, Vanessa Braun, Vanessa Lebouc, Zana Marin, Sulabh Patel & Gregoire Schwach. (2023) Reversible protein complexes as a promising avenue for the development of high concentration formulations of biologics. International Journal of Pharmaceutics 648, pages 123616.
Crossref
Crossref
Paulina Dabrowska‐Schlepp, Andreas Busch, Jin‐Song Shen, Rachel Y. Cheong, Lone Bruhn Madsen, Daniel Mascher, Raphael Schiffmann & Andreas Schaaf. (2023)
Comparison of efficacy between subcutaneous and intravenous application of
moss‐aGal
in the mouse model of Fabry disease
. JIMD Reports 64:6, pages 460-467.
Crossref
Crossref
Vivek D. Sree, John D. Toaquiza-Tubon, Jordanna Payne, Luis Solorio & Adrian Buganza Tepole. (2023) Damage and Fracture Mechanics of Porcine Subcutaneous Tissue Under Tensile Loading. Annals of Biomedical Engineering 51:9, pages 2056-2069.
Crossref
Crossref
Aiman Daifallah, Husam Salameh, Bushra Suwan, Maha Rabayaa, Zain Khayyat, Mohammad Hasoon, Maisa A. Nazzal, Samah Al-Jabi & Sa’ed H. Zyoud. (2023) Cancer-related post-treatment pain and its impact on treatment satisfaction with medication in women with breast cancer: a cross-sectional study from Palestine. Supportive Care in Cancer 31:9.
Crossref
Crossref
Gregory Jones, Lingxue Zeng & Jonghan Kim. (2023) Application of Allometric Scaling to Nanochelator Pharmacokinetics. ACS Omega 8:30, pages 27256-27263.
Crossref
Crossref
M. Burotto, Z. Zvirbule, A. Mochalova, Y. Runglodvatana, L. Herraez-Baranda, S.N. Liu, P. Chan, E. Shearer-Kang, X. Liu, N. Tosti, J.A. Zanghi, B. Leutgeb & E. Felip. (2023) IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications. Annals of Oncology 34:8, pages 693-702.
Crossref
Crossref
Mika Futaki, Kazuya Inamura, Miyu Hashimoto, Shunsaku Motegi, Shoko Itakura, Kenji Sugibayashi & Hiroaki Todo. (2023) Effects of Intradermal Administration Volume Using a Hollow Microneedle on the Pharmacokinetics of Fluorescein Isothiocyanate Dextran (M.W. 4,000). Pharmaceutical Research 40:8, pages 1953-1963.
Crossref
Crossref
German V. Kukushkin, Marina V. Zhuravleva & Dmitry E. Yurov. (2023) Influence of drugs with hyaluronidase activity on the survival of animals with a purulent-inflammatory process in the abdominal organs. Medical Journal of the Russian Federation 29:2, pages 99-105.
Crossref
Crossref
Marina Caskey. (2023) High volume subcutaneous delivery of long-acting HIV bNAbs. The Lancet HIV 10:4, pages e211-e212.
Crossref
Crossref
Sharana Mahomed, Nigel Garrett, Edmund V Capparelli, Farzana Osman, Nonhlanhla N Mkhize, Ishana Harkoo, Tanuja N Gengiah, Leila E Mansoor, Cheryl Baxter, Derseree Archary, Nonhlanhla Yende-Zuma, Natasha Samsunder, Kevin Carlton, Sandeep Narpala, Adrian B McDermott, Nicole A Doria-Rose, Penny L Moore, Lynn Morris, Quarraisha Abdool Karim, John R Mascola & Salim S Abdool Karim. (2023) Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial. The Lancet HIV 10:4, pages e230-e243.
Crossref
Crossref
Ana Homšek, Jelena Spasić, Neda Nikolić, Tatjana Stanojković, Marija Jovanović, Branislava Miljković & Katarina M Vučićević. (2022) Pharmacokinetic characterization, benefits and barriers of subcutaneous administration of monoclonal antibodies in oncology. Journal of Oncology Pharmacy Practice 29:2, pages 431-440.
Crossref
Crossref
Wanshan Hu, Tingting Peng, Yao Huang, Tao Ren, Hongyu Chen, Yangyan Chen, Disang Feng, Chuanbin Wu & Xin Pan. (2023) Hyaluronidase-powered microneedles for significantly enhanced transdermal delivery efficiency. Journal of Controlled Release 353, pages 380-390.
Crossref
Crossref
Hanifeh Shariatifar, Fateme Ranjbarian, Fahimeh Hajiahmadi & Alireza Farasat. (2022) A comprehensive review on methotrexate containing nanoparticles; an appropriate tool for cancer treatment. Molecular Biology Reports 49:11, pages 11049-11060.
Crossref
Crossref
Alexandre Bordat, Tanguy Boissenot, Nada Ibrahim, Marianne Ferrere, Manon Levêque, Léa Potiron, Stéphanie Denis, Sébastien Garcia-Argote, Olivia Carvalho, Jérôme Abadie, Catherine Cailleau, Grégory Pieters, Nicolas Tsapis & Julien Nicolas. (2022) A Polymer Prodrug Strategy to Switch from Intravenous to Subcutaneous Cancer Therapy for Irritant/Vesicant Drugs. Journal of the American Chemical Society 144:41, pages 18844-18860.
Crossref
Crossref
Aubin Pitiot, Nathalie Heuzé-Vourc’h & Thomas Sécher. (2022) Alternative Routes of Administration for Therapeutic Antibodies—State of the Art. Antibodies 11:3, pages 56.
Crossref
Crossref
Sharana Mahomed, Nigel Garrett, Edmund V Capparelli, Farzana Osman, Ishana Harkoo, Nonhlanhla Yende-Zuma, Tanuja N Gengiah, Derseree Archary, Natasha Samsunder, Cheryl Baxter, Nonhlanhla N Mkhize, Tandile Modise, Kevin Carlton, Adrian McDermott, Penny L Moore, Quarraisha Abdool Karim, Dan H Barouch, Patricia E Fast, John R Mascola, Julie E Ledgerwood, Lynn Morris & Salim S Abdool Karim. (2022) Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention. The Journal of Infectious Diseases 226:3, pages 510-520.
Crossref
Crossref
Zita Chovancová. (2022) Clinical experience with facilitated subcutaneous immunoglobulin treatment. Klinická farmakologie a farmacie 36:2, pages 38-42.
Crossref
Crossref
Paul J. Carter & Arvind Rajpal. (2022) Designing antibodies as therapeutics. Cell 185:15, pages 2789-2805.
Crossref
Crossref
Alisa Klepach, Huyen Tran, Faiz Ahmad Mohammed & Mohamed E.H. ElSayed. (2022) Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery. Advanced Drug Delivery Reviews 186, pages 114322.
Crossref
Crossref
Airi Harui & Michael D. Roth. (2022) Hyaluronidase Enhances Targeting of Hydrogel-Encapsulated Anti-CTLA-4 to Tumor Draining Lymph Nodes and Improves Anti-Tumor Efficacy. Gels 8:5, pages 284.
Crossref
Crossref
Yara Al Ojaimi, Timothée Blin, Juliette Lamamy, Matthieu Gracia, Aubin Pitiot, Caroline Denevault-Sabourin, Nicolas Joubert, Jean-Pierre Pouget, Valérie Gouilleux-Gruart, Nathalie Heuzé-Vourc’h, Débora Lanznaster, Sophie Poty & Thomas Sécher. (2022) Therapeutic antibodies – natural and pathological barriers and strategies to overcome them. Pharmacology & Therapeutics 233, pages 108022.
Crossref
Crossref
Yiqiong Liu, Dailin Xu, Ying Liu, Xiao Zheng, Jie Zang, Wanli Ye, Yuge Zhao, Ruiqing He, Shuangrong Ruan, Tingting Zhang, Haiqing Dong, Yan Li & Yongyong Li. (2022) Remotely boosting hyaluronidase activity to normalize the hypoxic immunosuppressive tumor microenvironment for photothermal immunotherapy. Biomaterials 284, pages 121516.
Crossref
Crossref
W Jiskoot, Andrea Hawe, Tim Menzen, David B. Volkin & Daan J.A. Crommelin. (2022) Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis?. Journal of Pharmaceutical Sciences 111:4, pages 861-867.
Crossref
Crossref
Tianyuan Ci, Wentao Zhang, Yingyu Qiao, Huangjuan Li, Jing Zang, Hongjun Li, Nianping Feng & Zhen Gu. (2022) Delivery strategies in treatments of leukemia. Chemical Society Reviews 51:6, pages 2121-2144.
Crossref
Crossref
Yao Huang, Tingting Peng, Wanshan Hu, XinYi Gao, Yangyan Chen, Qian Zhang, Chuanbin Wu & Xin Pan. (2022) Fully armed photodynamic therapy with spear and shear for topical deep hypertrophic scar treatment. Journal of Controlled Release 343, pages 408-419.
Crossref
Crossref
Nafiseh Sanei Ata-abadi, Mahboobeh Forouzanfar, Kianoush Dormiani, Shiva Rouhollahi Varnosfaderani, Leila Pirjamali, Mohammad Hossein Nasr-Esfahani & Reza Moradi Hajidavaloo. (2022) Site-specific integration as an efficient method for production of recombinant human hyaluronidase PH20 in semi-adherent cells. Applied Microbiology and Biotechnology 106:4, pages 1459-1473.
Crossref
Crossref
Wang Wang Lee & Claire M. Patterson. 2022. Biopharmaceutics. Biopharmaceutics
253
263
.
Michael J. Harvey, Yi Zhong, Eric Morris, Jacob N. Beverage, Robert S. Epstein & Anita J. Chawla. (2022) Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma. PLOS ONE 17:1, pages e0261336.
Crossref
Crossref
Susanne PageTarik KhanPeter KühlGregoire SchwachKirsten Storch & Hitesh Chokshi. (2022) Patient Centricity Driving Formulation Innovation: Improvements in Patient Care Facilitated by Novel Therapeutics and Drug Delivery Technologies. Annual Review of Pharmacology and Toxicology 62:1, pages 341-363.
Crossref
Crossref
Wendy D. Woodley, Didier R. Morel, Diane E. Sutter, Ronald J. Pettis & Natasha G. Bolick. (2021) Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults. Clinical and Translational Science 15:1, pages 92-104.
Crossref
Crossref
Jennifer N. Hennigan & Michael D. Lynch. (2022) The past, present, and future of enzyme-based therapies. Drug Discovery Today 27:1, pages 117-133.
Crossref
Crossref
Seth Eisenberg. (2021) Subcutaneous Administration: Evolution, Challenges, and the Role of Hyaluronidase. Clinical Journal of Oncology Nursing 25:6, pages 663-671.
Crossref
Crossref
Martin Sindelar, Jana Jilkova, Lukas Kubala, Vladimir Velebny & Kristyna Turkova. (2021) Hyaluronidases and hyaluronate lyases: From humans to bacteriophages. Colloids and Surfaces B: Biointerfaces 208, pages 112095.
Crossref
Crossref
Michael J. Dolton, Aaron Chesterman, Anita Moein, Kaycee M. Sink, Ariel Waitz, Kathleen Blondeau, Geoffrey A. Kerchner, Nan Hu, Logan Brooks, Monica K. Wetzel‐Smith, Amanda Roden, Ajay Deshmukh, Kun Peng, Montserrat Carrasco‐Triguero, Jill Smith, Susanne Ostrowitzki & Angelica Quartino. (2021) Safety, Tolerability, and Pharmacokinetics of High‐Volume Subcutaneous Crenezumab, With and Without Recombinant Human Hyaluronidase in Healthy Volunteers. Clinical Pharmacology & Therapeutics 110:5, pages 1337-1348.
Crossref
Crossref
Kenta Haraya & Tatsuhiko Tachibana. (2021) Estimation of Clearance and Bioavailability of Therapeutic Monoclonal Antibodies from Only Subcutaneous Injection Data in Humans Based on Comprehensive Analysis of Clinical Data. Clinical Pharmacokinetics 60:10, pages 1325-1334.
Crossref
Crossref
Enriqueta Felip, Mauricio Burotto, Zanete Zvirbule, Luis A. Herraez‐Baranda, Pascal Chanu, Smita Kshirsagar, Vidya Maiya, Phyllis Chan, Emanuela Pozzi, Mathilde Marchand, Marion Monchalin, Kunihiko Tanaka, Nadia Tosti, Bei Wang & Eleonora Restuccia. (2021) Results of a Dose‐Finding Phase 1b Study of Subcutaneous Atezolizumab in Patients With Locally Advanced or Metastatic Non–Small Cell Lung Cancer. Clinical Pharmacology in Drug Development 10:10, pages 1142-1155.
Crossref
Crossref
Abhay TharmattDanish MalhotraHamayal SharmaNeena Bedi. (2021) Pharmaceutical Perspective in Wearable Drug Delivery Systems. ASSAY and Drug Development Technologies 19:6, pages 386-401.
Crossref
Crossref
David W. Kang, Beate Bittner, Barry J. Sugarman, Monica L. Zepeda & Marie A. Printz. (2021) Dispersive effects and focused biodistribution of recombinant human hyaluronidase PH20: A locally acting and transiently active permeation enhancer. PLOS ONE 16:7, pages e0254765.
Crossref
Crossref
Ran Cheng, Nadine Taleb, Meggie Stainforth-Dubois & Rémi Rabasa-Lhoret. (2021) The promising future of insulin therapy in diabetes mellitus. American Journal of Physiology-Endocrinology and Metabolism 320:5, pages E886-E890.
Crossref
Crossref
Xingcheng Xiong, Juanli Xi, Qian Liu, Cixiao Wang, Zeyou Jiang, Su‐Yang Yue, Lei Shi & Yuping Rong. (2021) Co‐expression of IL‐7 and PH20 promote anti‐GPC3 CAR‐T tumour suppressor activity in vivo and in vitro. Liver International 41:5, pages 1033-1043.
Crossref
Crossref
Andrea Allmendinger. (2021) Opportunities in an Evolving Pharmaceutical Development Landscape: Product Differentiation of Biopharmaceutical Drug Products. Pharmaceutical Research 38:5, pages 739-757.
Crossref
Crossref
Ajai Chari, Paula Rodriguez‐Otero, Helen McCarthy, Kenshi Suzuki, Vania Hungria, Anna Sureda Balari, Aurore Perrot, Cyrille Hulin, Hila Magen, Shinsuke Iida, Vladimir Maisnar, Lionel Karlin, Ludek Pour, Dolly A. Parasrampuria, Tara Masterson, Michele Kosh, Shiyi Yang, Maria Delioukina, Ming Qi, Robin Carson & Cyrille Touzeau. (2020) Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study. British Journal of Haematology 192:5, pages 869-878.
Crossref
Crossref
Wenzhan Yang, Shobha N. Bhattachar, Phenil J. Patel, Margaret Landis, Dipal Patel, Darren L. Reid & Marieta Duvnjak Romic. (2021) Modulating target engagement of small molecules via drug delivery: approaches and applications in drug discovery and development. Drug Discovery Today 26:3, pages 713-723.
Crossref
Crossref
Nicole L. Jarvi & Sathy V. Balu-Iyer. (2021) Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins. BioDrugs 35:2, pages 125-146.
Crossref
Crossref
Wenliang Dong, Min Chen, Jiaxue Wang, Lin Xia, Qian Wang, Xiaoyan Nie, Yufei Feng & Yi Fang. (2021) rHuPH20-facilitated subcutaneous administration of monoclonal antibodies in cancer therapy. Immunotherapy 13:1, pages 79-88.
Crossref
Crossref
Luiza Helena Gremski, Fernando Hitomi Matsubara, Hanna Câmara da Justa, Zelinda Schemczssen-Graeff, Antonielle Beatriz Baldissera, Pedro Henrique de Caires Schluga, Isabel de Oliveira Leite, Marianna Boia-Ferreira, Ana Carolina Martins Wille, Andrea Senff-Ribeiro & Silvio Sanches Veiga. (2021) Brown spider venom toxins: what are the functions of astacins, serine proteases, hyaluronidases, allergens, TCTP, serpins and knottins?. Journal of Venomous Animals and Toxins including Tropical Diseases 27.
Crossref
Crossref
Galen H. Shi, Robert J. Connor, David S. Collins & David W. Kang. (2021) Subcutaneous Injection Performance in Yucatan Miniature Pigs with and without Human Hyaluronidase and Auto-injector Tolerability in Humans. AAPS PharmSciTech 22:1.
Crossref
Crossref
Larysa Sanchez, Joshua Richter, Hearn Jay Cho, Sundar Jagannath, Deepu Madduri, Samir Parekh, Shambavi Richard, Lowena Tam, Daniel Verina & Ajai Chari. (2021) Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myeloma. Therapeutic Advances in Hematology 12, pages 204062072098707.
Crossref
Crossref
Lucas Gutierrez, Nina S. Cauchon, Twinkle R. Christian, Michael J. Giffin & Michael J. Abernathy. (2020) The Confluence of Innovation in Therapeutics and Regulation: Recent CMC Considerations. Journal of Pharmaceutical Sciences 109:12, pages 3524-3534.
Crossref
Crossref
Manuel Sánchez-Félix, Matt Burke, Hunter H. Chen, Claire Patterson & Sachin Mittal. (2020) Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge. Advanced Drug Delivery Reviews 167, pages 66-77.
Crossref
Crossref
Ken-ichi Izutsu, Akiko Usui, Eiichi Yamamoto, Yasuhiro Abe, Hiroyuki Yoshida & Yukihiro Goda. (2020) Effect of Complex Coacervation with Hyaluronic Acid on Protein Transition in a Subcutaneous Injection Site Model System. Chemical and Pharmaceutical Bulletin 68:11, pages 1109-1112.
Crossref
Crossref
Sharana Mahomed, Nigel Garrett, Quarraisha A Karim, Nonhlanhla Y Zuma, Edmund Capparelli, Cheryl Baxter, Tanuja Gengiah, Derseree Archary, Natasha Samsunder, Nicole D Rose, Penny Moore, Carolyn Williamson, Dan H Barouch, Patricia E Fast, Bruno Pozzetto, Catherine Hankins, Kevin Carlton, Julie Ledgerwood, Lynn Morris, John Mascola & Salim Abdool Karim. (2020) Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial. BMJ Open 10:11, pages e042247.
Crossref
Crossref
Robert J. Connor, Darin M. Taverna, Karla Thrall, Michael J. LaBarre & David W. Kang. (2020) Use of computed tomography to assess subcutaneous drug dispersion with recombinant human hyaluronidase PH20 in a swine model. Journal of Pharmacological and Toxicological Methods 106, pages 106936.
Crossref
Crossref
Andrea Allmendinger & Stefan Fischer. (2020) Tissue Resistance during Large-Volume Injections in Subcutaneous Tissue of Minipigs. Pharmaceutical Research 37:10.
Crossref
Crossref
Gregory Jones, Sumanta Kumar Goswami, Homan Kang, Hak Soo Choi & Jonghan Kim. (2020) Combating iron overload: a case for deferoxamine-based nanochelators. Nanomedicine 15:13, pages 1341-1356.
Crossref
Crossref
Robert J. Connor, Barbara Blouw, Jessica Cowell, Kelly Chen, Chunmei Zhao & David W. Kang. (2020) A Preclinical Investigation into the Effects of Aging on Dermal Hyaluronan Properties and Reconstitution Following Recombinant Human Hyaluronidase PH20 Administration. Dermatology and Therapy 10:3, pages 503-513.
Crossref
Crossref
Erinc Sahin & Smeet Deshmukh. (2019) Challenges and Considerations in Development and Manufacturing of High Concentration Biologics Drug Products. Journal of Pharmaceutical Innovation 15:2, pages 255-267.
Crossref
Crossref
David S. Collins, Manuel Sánchez-Félix, Advait V. Badkar & Randall Mrsny. (2020) Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics. Journal of Controlled Release 321, pages 475-482.
Crossref
Crossref
Terri Lynn Shigle & Qaiser Bashir. (2020) Advancement in monoclonal antibody therapy for multiple myeloma. The Lancet Haematology 7:5, pages e354-e355.
Crossref
Crossref
Mario RegazziJoseè Golay & Mariadelfina Molinaro. (2020) Monoclonal Antibody Monitoring: Clinically Relevant Aspects, A Systematic Critical Review. Therapeutic Drug Monitoring 42:1, pages 45-56.
Crossref
Crossref
Marie A. Printz, Samuel S. Dychter, Emanuel P. DeNoia, Rena Harrigan, Barry J. Sugarman, Monica Zepeda, Jennifer Souratha, David W. Kang & Daniel C. Maneval. (2020) A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Hyaluronidase PH20 Administered Intravenously in Healthy Volunteers. Current Therapeutic Research 93, pages 100604.
Crossref
Crossref
Orlagh M. Feeney, Gracia Gracia, Daniel H.S. Brundel, Natalie L. Trevaskis, Enyuan Cao, Lisa M. Kaminskas & Christopher J.H. Porter. (2020) Lymph-directed immunotherapy – Harnessing endogenous lymphatic distribution pathways for enhanced therapeutic outcomes in cancer. Advanced Drug Delivery Reviews 160, pages 115-135.
Crossref
Crossref
M.A. Reymond & A. Königsrainer. 2020. Drug Delivery Trends. Drug Delivery Trends
197
214
.
Sabah N. Rezvani, Jinnan Chen, Jun Li, Ron Midura, Valbona Cali, John D. Sandy, Anna Plaas & Vincent M. Wang. (2019) In‐Vivo Efficacy of Recombinant Human Hyaluronidase (rHuPH20) Injection for Accelerated Healing of Murine Retrocalcaneal Bursitis and Tendinopathy. Journal of Orthopaedic Research 38:1, pages 59-69.
Crossref
Crossref
Martin R Gaudinski, Katherine V Houser, Nicole A Doria-Rose, Grace L Chen, Ro Shauna S Rothwell, Nina Berkowitz, Pamela Costner, LaSonji A Holman, Ingelise J Gordon, Cynthia S Hendel, Florence Kaltovich, Michelle Conan-Cibotti, Margarita Gomez Lorenzo, Cristina Carter, Sandra Sitar, Kevin Carlton, Jason Gall, Carolyn Laurencot, Bob C Lin, Robert T Bailer, Adrian B McDermott, Sung-Youl Ko, Amarendra Pegu, Young D Kwon, Peter D Kwong, Aryan M Namboodiri, Janardan P Pandey, Richard Schwartz, Frank Arnold, Zonghui Hu, Lily Zhang, Yunda Huang, Richard A Koup, Edmund V Capparelli, Barney S Graham, John R Mascola, Julie E Ledgerwood, Floreliz Mendoza, Laura Novik, Kathy Zephir, William Whalen, Brenda Larkin, Jamie Saunders, Jennifer Cunningham, Carol Levinson, Xiaolin Wang, Sarah Plummer, Milalynn Victorino, Abidemi Ola, Catina Boyd, Nilusha Jayasinghe, Preeti Apte, Cora Trelles Cartagena, Renunda Hicks, Pernell Williams, Olga Vasilenko, Galina Yamshchikov, Maria Burgos Florez, Iris Pittman, Lucio Gama, Joseph Casazza, Hope DeCederfelt, KC Cheng & Judy Stein. (2019) Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial. The Lancet HIV 6:10, pages e667-e679.
Crossref
Crossref